Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Solifenacin Succinate for Overactive Bladder in Parkinson's Disease
NCT01018264Phase 4Completed
- Sponsor
- University of South Florida
- Start
- Jan 2010
- Primary completion
- Aug 2014
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
A Phase 4 trial of solifenacin in overactive bladder (OAB), sponsored by University of South Florida. Started Jan 2010; status: completed.
02
Drugs
solifenacin
03
Conditions
overactive bladder (OAB)
Beyond the preview
Go deeper on NCT01018264.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01018264.